New: Instantly spot drawdowns, dips, insider moves, and breakout themes across Maps and Screener.

Learn More

Is Rockwell Medical (RMTI) Stock Undervalued Right Now?

By Zacks Equity Research | January 28, 2026, 9:40 AM

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.

Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.

Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.

One company value investors might notice is Rockwell Medical (RMTI). RMTI is currently sporting a Zacks Rank #2 (Buy), as well as an A grade for Value.

Investors should also recognize that RMTI has a P/B ratio of 1.49. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. This stock's P/B looks attractive against its industry's average P/B of 2.87. RMTI's P/B has been as high as 5.68 and as low as 0.86, with a median of 1.72, over the past year.

Value investors also use the P/S ratio. The P/S ratio is calculated as price divided by sales. This is a popular metric because sales are harder to manipulate on an income statement, so they are often considered a better performance indicator. RMTI has a P/S ratio of 0.6. This compares to its industry's average P/S of 1.54.

These figures are just a handful of the metrics value investors tend to look at, but they help show that Rockwell Medical is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, RMTI feels like a great value stock at the moment.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Rockwell Medical, Inc. (RMTI): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Latest News